Average Co-Inventor Count = 10.02
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (14 from 3,923 patents)
2. Cardiome Pharma Corp. (3 from 36 patents)
3. Novartis Pharma Gmbh (8 patents)
17 patents:
1. 12071441 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
2. 11912715 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
3. 11629149 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
4. 11098051 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
5. 10369138 - Monobactam organic compounds for the treatment of bacterial infections
6. 10160764 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
7. 9566312 - Cyclic peptides and use as medicines
8. 9174978 - Monobactam organic compounds for the treatment of bacterial infections
9. 9072696 - Cyclic peptides and use as medicines
10. 8445527 - Organic compounds and their uses
11. 8222425 - Organic compounds and their uses
12. 8211932 - Organic compounds and their uses
13. 8022098 - Deuterated aminocyclohexyl ether compounds and processes for preparing same
14. 8008263 - Organic compounds and their uses
15. 7825152 - Organic compounds and their uses